Orthopediatrics annual gross margin
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Orthopediatrics's gross margin was 73.05% for fiscal 2025.
View full Orthopediatrics company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 73.05% | +0.47 pp |
| 2024 | 2024-12-31 | 72.58% | −2.22 pp |
| 2023 | 2023-12-31 | 74.80% | +0.67 pp |
| 2022 | 2022-12-31 | 74.14% | −0.73 pp |
| 2021 | 2021-12-31 | 74.86% | −2.56 pp |
| 2020 | 2020-12-31 | 77.42% | +2.14 pp |
| 2019 | 2019-12-31 | 75.28% | +1.13 pp |
| 2018 | 2018-12-31 | 74.15% | −1.37 pp |
| 2017 | 2017-12-31 | 75.52% | +4.82 pp |
| 2016 | 2016-12-31 | 70.69% | +0.91 pp |
| 2015 | 2015-12-31 | 69.79% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 74.27% | +2.20 pp |
| Q1 2026 | 2026-03-31 | 73.09% | +0.09 pp |
| Q4 2025 | 2025-12-31 | 73.22% | +5.69 pp |
| Q3 2025 | 2025-09-30 | 73.92% | +0.51 pp |
| Q2 2025 | 2025-06-30 | 72.07% | −5.20 pp |
| Q1 2025 | 2025-03-31 | 73.00% | +1.00 pp |
| Q4 2024 | 2024-12-31 | 67.53% | −3.50 pp |
| Q3 2024 | 2024-09-30 | 73.41% | −4.03 pp |
| Q2 2024 | 2024-06-30 | 77.27% | +1.37 pp |
| Q1 2024 | 2024-03-31 | 72.00% | −2.59 pp |
| Q4 2023 | 2023-12-31 | 71.02% | +2.55 pp |
| Q3 2023 | 2023-09-30 | 77.44% | +3.36 pp |
| Q2 2023 | 2023-06-30 | 75.90% | +0.03 pp |
| Q1 2023 | 2023-03-31 | 74.59% | −4.70 pp |
| Q4 2022 | 2022-12-31 | 68.48% | −4.39 pp |
| Q3 2022 | 2022-09-30 | 74.07% | +0.09 pp |
| Q2 2022 | 2022-06-30 | 75.87% | −0.71 pp |
| Q1 2022 | 2022-03-31 | 79.28% | +3.22 pp |
| Q4 2021 | 2021-12-31 | 72.87% | −7.02 pp |
| Q3 2021 | 2021-09-30 | 73.98% | −5.45 pp |
| Q2 2021 | 2021-06-30 | 76.58% | +2.56 pp |
| Q1 2021 | 2021-03-31 | 76.06% | +1.39 pp |
| Q4 2020 | 2020-12-31 | 79.89% | +3.64 pp |
| Q3 2020 | 2020-09-30 | 79.44% | +2.81 pp |
| Q2 2020 | 2020-06-30 | 74.02% | −0.81 pp |
| Q1 2020 | 2020-03-31 | 74.67% | +1.97 pp |
| Q4 2019 | 2019-12-31 | 76.25% | +4.07 pp |
| Q3 2019 | 2019-09-30 | 76.62% | +0.92 pp |
| Q2 2019 | 2019-06-30 | 74.83% | +0.08 pp |
| Q1 2019 | 2019-03-31 | 72.70% | −1.05 pp |
| Q4 2018 | 2018-12-31 | 72.17% | −3.44 pp |
| Q3 2018 | 2018-09-30 | 75.71% | −0.99 pp |
| Q2 2018 | 2018-06-30 | 74.75% | +0.93 pp |
| Q1 2018 | 2018-03-31 | 73.75% | −2.21 pp |
| Q4 2017 | 2017-12-31 | 75.61% | +4.99 pp |
| Q3 2017 | 2017-09-30 | 76.69% | — |
| Q2 2017 | 2017-06-30 | 73.82% | — |
| Q1 2017 | 2017-03-31 | 75.96% | — |
| Q3 2016 | 2016-09-30 | 70.62% | — |
Over the last five reported fiscal years, Orthopediatrics's gross margin decreased from 77.42% to 73.05%, a change of −4.37 percentage points. The latest reported quarter, Q2 2026, shows 74.27%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Orthopediatrics filings at SEC.gov ↗